• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • About
  • Contact Us
WeedWeek

WeedWeek

WeedWeek is the best way to keep up with the green rush

  • Membership
  • My Account
  • LinkedIn
  • Instagram
  • Twitter
  • Politics
  • Money
  • Ops
  • Brands
  • Culture
  • Events

HARVARD, MIT RECEIVE $9M FOR MED RESEARCH

joe daniel price/ Getty Images

By Alex Halperin
05/06/2019 04:18 AM GMT-0700
FacebookTweetPin

An alumni of Harvard and MIT who’s now a cannabis investor donated $9M to the schools to study marijuana’s medical value. The donor Charles R. “Bob” Broderick invests in cannabis through family office Uji Capital. He will not have any say over the research he’s funding.
boston globe

  • MIT researchers plan to study the effects of cannabis on people with schizophrenia, about half of whom use cannabis heavily. Other MIT researchers will study autism, and Huntington’s disease.
  • Half of the grant goes to Harvard where 30 scientists and doctors will study “the effects of marijuana ingredients on brain cell function and the connections between brain cells, testing purified ingredients on mice and rats.”

Quick Hits

  1. Facebook showed how its AI technology can distinguish between pictures of cannabis and broccoli.
    marijuana moment
  2. A study found using cannabis and tobacco together can contribute to low function among young adults.
    eurekalert!
 

Share:
FacebookTweetPin
Filed Under:
Investing & Capital

Primary Sidebar

Recent Webinar

Growth in a Tight Market

WeedWeek Wonks: Growth in a Tight Market

Duration 60 minutes
Speakers Leah Heise, Alex Halperin

RSVP

Join WeedWeek California Pro Today!

WeedWeek Pro is the essential news and information resource for California cannabis professionals.

  • Access the Weedweek California Pro Newsletter
  • Access the California Tax and License Maps
  • Steep discounts on job posts in the WeedWeek career center
Sign Up

Get a risk-free 14 day trial for FREE!

Most Read

  • Regulation & Compliance

    EXCLUSIVE: We tested top Calif. prerolls for potency inflation

  • Regulation & Compliance

    Exclusive: Does Stiiizy have a diiiversiiion problem?

  • Industry Voices

    Calif. interstate commerce law opens pathway for licensed operators

Related Articles

See More Investing & Capital Articles
Investing & Capital

Who will back Pelorus’s $1B “roll up”?

dcc
Investing & Capital

SCOOP: Catalyst slams DCC ahead of diversion trial

What happened to Statehouse?
Investing & Capital

What happened to Statehouse?

Become a member and get access to exclusive content.

Join Now!

Footer

Join WeedWeek Pro

Become A Member Today and Get Access to Exclusive Content. Join here

Follow us

Follow WeedWeek for more content.

  • Instagram
  • LinkedIn
  • Twitter
  • About
  • Privacy Policy
  • Terms & Conditions
  • Contact
  • Advertise

RegStream Media Group © 2025. All Rights Reserved